Navigation Links
Perrigo Expands Infant Formula Distribution in China With Founder Group
Date:10/19/2011

ALLEGAN, Mich., Oct. 19, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has entered into a supply agreement with Founder Pharma Co., Ltd., a wholly owned subsidiary of publicly listed Southwest Synthetic Pharmaceutical Corp., Ltd. (SZSE: 000788).  Perrigo will supply infant formula manufactured in its U.S. facilities, for sale and distribution by Founder Pharma in China.

Perrigo Chairman and CEO Joseph C. Papa stated, "Southwest Synthetic is an exciting partner given its strong reputation and healthcare focus. Perrigo's high quality products and Southwest Synthetic's strong brand, marketing, and distribution should be a winning combination in the world's most robust infant formula market."

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API). The Company is the world's largest manufacturer of OTC pharmaceutical products and infant formulas, both for the store brand market. The Company's primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico, the United Kingdom and Australia. Visit Perrigo on the Internet (http://www.perrigo.com).

Southwest Synthetic is located in Chongqing, China and is the largest manufacturing, R&D, and exporting enterprise of biological and chemical synthetic pharmaceutical products in southwest China. It is also a key enterprise in China's pharmaceutical industry and is one of China's pharmaceutical enterprises with the most international approvals. In the past 2 to 3 years, it has completed two consolidations and built an industry chain from biological and chemical pharmaceuticals to healthcare products distribution. Visit Southwest Synthetic on the Internet (http://www.fsspc.com/en/)

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential" or other comparable terminology. The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections.  While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company's control. These and other important factors, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended June 25, 2011, as well as the Company's subsequent filings with the Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements in this press release are made only as of the date hereof, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Perrigo Company Will Release First Quarter Fiscal 2012 Results On October 27, 2011
2. Perrigo Company Confirms FDA Tentative Approval for Clobetasol Propionate Emulsion Foam
3. Perrigo to Host Analyst Day on October 5, 2011 at the TASE, Tel Aviv Stock Exchange in Tel Aviv, Israel
4. Perrigo to Host Analyst Day on September 27, 2011 at the NASDAQ MarketSite in Times Square
5. Perrigo Announces FDA Final Approval for Ketoconazole Foam, 2%
6. Perrigo Company Will Release Fourth Quarter Fiscal 2011 Results on August 16, 2011
7. Watson Enters into Agreement to Acquire Products Related to Perrigos Acquisition of Paddock Laboratories
8. Perrigo Closes Acquisition of Paddock Labs
9. Perrigo Receives FDA Approval to Market Coated Cinnamon Nicotine Gum
10. Perrigo Provides Update on Acquisition of Paddock Labs
11. Perrigo Announces Launch of the Generic Version of Nasacort® AQ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and Nutrition ... the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market ... can be easily incorporated into liquid products, while reducing costs to end users. , ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , ... mock evacuation of the facility as part of a disaster drill on October 3rd. ... EMS and Shelton City Emergency Manager, as well as the Connecticut Long Term ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading ... to advocate for action towards gender equality at their inaugural Summit in New York ... globe, and reached a social audience of over 3 million. To watch the Mobilize ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
Breaking Medicine News(10 mins):